N,N-dibenzyl-2-(4-(N-isobutylsulfamoyl)phenoxy)acetamide

ID: ALA4434895

PubChem CID: 126200721

Max Phase: Preclinical

Molecular Formula: C26H30N2O4S

Molecular Weight: 466.60

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)CNS(=O)(=O)c1ccc(OCC(=O)N(Cc2ccccc2)Cc2ccccc2)cc1

Standard InChI:  InChI=1S/C26H30N2O4S/c1-21(2)17-27-33(30,31)25-15-13-24(14-16-25)32-20-26(29)28(18-22-9-5-3-6-10-22)19-23-11-7-4-8-12-23/h3-16,21,27H,17-20H2,1-2H3

Standard InChI Key:  CJJPIMDYJRXNIG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
   34.5209  -18.9500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.1125  -19.6667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   34.9373  -19.6620    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   26.2527  -18.4583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2516  -19.2857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9664  -19.6986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6828  -19.2851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6800  -18.4547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9646  -18.0455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3929  -18.0395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1089  -18.4493    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.8219  -18.0341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1121  -19.2742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8280  -19.6841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8296  -20.5094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5447  -20.9191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2586  -20.5039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2528  -19.6746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5371  -19.2687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5379  -18.4439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8188  -17.2091    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2508  -18.0288    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.9668  -18.4385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9670  -19.2636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6822  -19.6733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3961  -19.2581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3904  -18.4288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6746  -18.0228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1168  -20.4919    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.8335  -20.9006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8379  -21.7257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5545  -22.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1255  -22.1419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 12 20  1  0
 12 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26  2  1  0
  2 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4434895

    ---

Associated Targets(Human)

PDK1 Tchem Pyruvate dehydrogenase kinase isoform 1 (2021 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK2 Tchem Pyruvate dehydrogenase kinase isoform 2 (894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK3 Tchem Pyruvate dehydrogenase kinase isoform 3 (60 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDK4 Tchem Pyruvate dehydrogenase kinase isoform 4 (177 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSP90AA1 Tchem Heat shock protein HSP90 (3606 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1650 (1118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BEAS-2B (690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 466.60Molecular Weight (Monoisotopic): 466.1926AlogP: 4.23#Rotatable Bonds: 11
Polar Surface Area: 75.71Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.43CX Basic pKa: CX LogP: 4.46CX LogD: 4.46
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.46Np Likeness Score: -1.32

References

1. Wu DM, Wang YJ, Fan SH, Zhang ZF, Shan Q, Lu J, Chen GQ, Zheng YL..  (2019)  High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.,  164  [PMID:30597326] [10.1016/j.ejmech.2018.12.051]
2. Wu DM, Wang YJ, Fan SH, Zhang ZF, Shan Q, Lu J, Chen GQ, Zheng YL..  (2019)  High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.,  164  [PMID:30597326] [10.1016/j.ejmech.2018.12.051]

Source